DOCMODE HEALTH IPO UPDATE
Unpacking Go Digit’s earnings; PEs in IPO-bound firms
Go Digit General Insurance reported its second consecutive full year of profit in fiscal 2024. This and more in today’s ETtech Top 5.
Surprise poll results impact startups' plans, and other top stories this week
In a week charged with political buzz, the BJP government came back to power after a stormy election, but without a full majority that left it dependent on the whims of its alliance partners. Unnerved, the markets went into a tailspin on counting day, with both benchmark indices, Sensex and Nifty50, dropping 8% intraday. They recovered a day later as hopes of a stable government revived.
Canara Bank starts IPO process to take Canara HSBC Life public
The IPO, if approved by the regulators including RBI, the Department of Financial Services, and the union government, will pave the way for Canara HSBC Life's listing on both exchanges.
Aadhar Housing Finance IPO fully booked on Day 2. Check subscription, GMP and other details
The IPO comprises fresh equity issue of up to Rs 1,000 crore and offer for sale (OFS) of up to Rs 2,000 crore by existing investors. Under the OFS, BCP Topco VII will offload shares.
Aadhar Housing Finance IPO booked 19% so far on the first day. Check subscription, GMP and other details
Aadhar Housing Finance IPO Status: Aadhar Housing Finance's IPO received 19% subscription on its first day, with QIB investors subscribing 32%, retail investors 14%, and non-institutional investors 12%.
FirstCry refiles IPO papers; Groww secures payment aggregator licence
FirstCry has refiled its draft IPO papers with market regulator Sebi with updated financials. More on this in today’s ETtech Top 5.
- Go To Page 1
Smaller IPOs an alternative for shrinking VC exits: Blume report
According to a report from Blume, startups which are not seeing a lot of interest from growth investors, or hitting a growth ceiling and ‘feel better to build profitably than burn for growth’ should be exploring IPOs.
Docmode Health Technologies shares list at 141% premium over IPO price
Shares of Docmode Health Technologies listed on NSE SME platform with a premium of 141%. The stock debuted at Rs 190.25, 141% higher than the offer price. The company's shares traded with a premium of Rs 42 in the unlisted market. The public offer of 8.49 lakh shares received strong response with an overall subscription of 215 times.
Docmode Health Technologies IPO: Check status, GMP, listing date and other details
Docmode Health Technologies IPO allotment status can be checked on the Bigshare Services website by following a step-by-step process. The company's shares in the unlisted market are commanding a premium of Rs 28, indicating potential listing gains of 35% when it debuts on the NSE SME platform on February 2. Docmode Health Technologies offers integrated learning solutions to healthcare professionals worldwide.
Fonebox IPO allotment: Check status, issue timeline, GMP, other details
Fonebox IPO allotment Status: Investors can check the allotment status of the SME initial public offering (IPO) of Fonebox Retail on the NSE. The IPO of Fonebox Retail was oversubscribed at 437.79, with over 127.39 crore share bids received against 29.1 lakh equity shares available for subscription. The retail individual investors portion received 85.60 crore shares bids, while the non-institutional investors got over 34.08 crore share bids. The company raised Rs 5.78 crore via anchor allotment, and the IPO is a fresh equity issue of up to 29.1 lakh equity shares.
Gabriel Pet Straps IPO: Check issue size, price band and other details
Gabriel Pet Straps IPO: The IPO of Gabriel Pet Straps opened for subscription today. The company plans to raise about Rs 54 crore through the public offer. Gabriel Pet Straps is engaged in the manufacturing and selling of pet straps widely used in packaging of heavy materials. The IPO is a fresh equity issue of up to 7.98 lakh equity shares. The company is offering its shares at Rs 101 apiece.
Nova Agritech IPO allotment expected soon. Check status, GMP, listing date and other details
Nova Agritech IPO allotment: Nova Agritech IPO received massive subscription of over 100 times, driven by heavy bidding from non-institutional and institutional investors. The share allotment for the public offer is expected to be finalized in the next two to three days.
Docmode Health Technologies IPO fully subscribed on first day. Check details
Docmode Health Technologies IPO was entirely a fresh issue of up to 8.49 lakh equity shares aggregating up to Rs 6.7 crore. The company has fixed a price band of Rs 79 apiece, and investors can bid for 1,600 shares in one lot.
Docmode Health Technologies IPO: Check issue size, price band and other details
The IPO of Docmode Health Tech, a company offering integrated learning solutions to healthcare professionals, opened for subscription. The company plans to raise about Rs 6.71 crore through the public offer. The IPO price band is set at Rs 79 per share, and the net proceeds will be used for IT infrastructure, working capital, and general corporate purposes. The IPO closes on January 30 and the shares will get listed on the NSE SME platform on February 2.
Medi Assist Healthcare IPO: What GMP signals ahead of listing tomorrow
If the current trends are sustained, the company's shares are expected to list with a premium of 8%. The issue was priced in the range of Rs 397-418.
Nova AgriTech IPO price band fixed at Rs 39-41 per share. Check details
Nova AgriTech IPO, which will open for subscription from January 22 to January 24, is looking to sell shares at Rs 39-41 apiece. The company plans to raise Rs 112 crore through a fresh equity issue and an offer for sale (OFS) of 77.5 lakh shares. The allocation for qualified institutional buyers (QIBs) is at 50%, for non-institutional investors (NIIs) at 15%, and for retail investors at 35%. Nova AgriTech's revenue in FY23 was Rs 210 crore with a profit of Rs 20.48 crore.
Nova AgriTech IPO to open on January 22. Check details
Nova AgriTech IPO comprises a fresh equity issue worth Rs 112 crore and an offer for sale (OFS) of 77.5 lakh shares. The price band for the IPO will be announced soon.
Park Hotels, Medi Assist get Sebi's approval to launch IPOs
According to the draft papers, the proposed IPO of Apeejay Surrendra Park Hotels comprises a fresh issue of equity shares worth Rs 650 crore and an offer for sale (OFS) of equity shares to the tune of Rs 400 crore by promoters and investor shareholders.
Dream run! Samvat 2079 IPOs have 90% success rate and 6 multibagger triumphs
Six IPOs have turned multibaggers in Samvat 2079 with the highest return of over 300% by Kaynes Technology. The other offers which have delivered over 100% returns till date include Plaza Wires, Cyient DL, Global Health, Senco Gold and Utkarsh Small Finance Bank.
Valiant Laboratories IPO opens Wednesday: What GMP signals ahead of subscription
The offer, which is priced at Rs 133-140 apiece, is completely a fresh equity issue of Rs 1.08 crore shares. Investors can bid for a minimum of 105 shares in one lot and in multiples thereof
Valiant Laboratories fixes price band at Rs 133-140 for its IPO
The company's IPO is completely a fresh equity issue of Rs 1.08 crore shares. About 50% of the offer is reserved for qualified institutional buyers, 15% for non-institutional investors and the rest 35% for retail investors.
Medi Assist Healthcare refiles draft papers with Sebi for 2.8 crore-share sale via IPO
The IPO is a complete offer for sale, wherein promoters and other shareholders plan to sell 28,028,168 shares of the company. If the IPO sails through this time, Medi Assist will be the first insurance third-party administrator (TPA) in India to be listed.
Indegene gets Sebi nod to float IPO
The IPO of Indegene consists of a fresh issue of equity shares worth up to Rs 950 crore and offer for sale of up to 3.63 crore equity shares by existing investors, according to the Draft Red Herring Prospectus
Nexus Select Trust REIT IPO sails through on Day 3
India's Rs 3,200 crore ($435m) initial public offering (IPO) of Blackstone-backed Nexus Select Trust, a real estate investment trust (REIT), was fully subscribed on the third day of bidding. The institutional investor segment was subscribed 1.32 times with other investors seeking 1.87 times. The issue is a mix of fresh-share offer and an offer for sale portion, gaining Rs 1,440 crore on the day before the issue opened from institutional investors. If the IPO touches the upperband of Rs 100, Nexus will have a market cap of Rs 15,150 crore, offering a pre-tax yield of 8% in FY24.
Mamaearth IPO on hold amid subdued market conditions: Report
Backed by investors such as Sequoia Capital and Belgium's Sofina, Mamaearth is now in a "wait and watch mode", a Reuters report said, citing turbulence in stock markets globally amid worries about the financial health of banks.
Global Health IPO: Here's how to check allotment status & GMP
The company's Rs 2,206 crore IPO was sold in the range of Rs 319-336 per share and received a positive investor response. It garnered over 9.5 times bids between November 3-7.
Global Health IPO subscribed 0.49x on day 2 of bidding
The IPO consists of a fresh issue of equity shares aggregating to Rs 500 crore and an offer for sale (OFS) of up to 5.08 crore equity shares from its promoters and existing shareholders. The net proceeds from the fresh issue will be utilised towards repayment or prepayment of borrowings, in full or part, of the subsidiaries, GHPPL and MHPL and general corporate purposes.
Global Health IPO kicks off: Can Medanta keep your portfolio in the pink of health?
Global Health operates and manages hospitals under the Medanta brand and the issue is open for subscription till November 7. Investors can bid for a minimum of 44 equity shares and in multiples thereof.
Global Health IPO received muted response on day 1; subscribed just 0.26x
The company is bringing the issue at EV/EBITDA multiple of 18x & EV/Sales multiple of 4x. Growth opportunities in existing facilities and diversification into new services, including digital health with experienced senior management team & institutional shareholder support is a decent issue, said Hem Securities.
Load More
